Synopsis
0
USDMF
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
Certificate Number : R1-CEP 2008-306 - Rev 01
Status : Valid
Issue Date : 2021-12-10
Type : Chemical
Substance Number : 1787
Siegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.
Certificate Number : R1-CEP 2015-124 - Rev 00
Status : Valid
Issue Date : 2021-05-06
Type : Chemical
Substance Number : 1787
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
57
PharmaCompass offers a list of Levomethadone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Levomethadone manufacturer or Levomethadone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levomethadone manufacturer or Levomethadone supplier.
A L-polamidon (TN) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-polamidon (TN), including repackagers and relabelers. The FDA regulates L-polamidon (TN) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-polamidon (TN) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L-polamidon (TN) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A L-polamidon (TN) supplier is an individual or a company that provides L-polamidon (TN) active pharmaceutical ingredient (API) or L-polamidon (TN) finished formulations upon request. The L-polamidon (TN) suppliers may include L-polamidon (TN) API manufacturers, exporters, distributors and traders.
click here to find a list of L-polamidon (TN) suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A L-polamidon (TN) CEP of the European Pharmacopoeia monograph is often referred to as a L-polamidon (TN) Certificate of Suitability (COS). The purpose of a L-polamidon (TN) CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of L-polamidon (TN) EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of L-polamidon (TN) to their clients by showing that a L-polamidon (TN) CEP has been issued for it. The manufacturer submits a L-polamidon (TN) CEP (COS) as part of the market authorization procedure, and it takes on the role of a L-polamidon (TN) CEP holder for the record. Additionally, the data presented in the L-polamidon (TN) CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the L-polamidon (TN) DMF.
A L-polamidon (TN) CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. L-polamidon (TN) CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of L-polamidon (TN) suppliers with CEP (COS) on PharmaCompass.
A L-polamidon (TN) written confirmation (L-polamidon (TN) WC) is an official document issued by a regulatory agency to a L-polamidon (TN) manufacturer, verifying that the manufacturing facility of a L-polamidon (TN) active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting L-polamidon (TN) APIs or L-polamidon (TN) finished pharmaceutical products to another nation, regulatory agencies frequently require a L-polamidon (TN) WC (written confirmation) as part of the regulatory process.
click here to find a list of L-polamidon (TN) suppliers with Written Confirmation (WC) on PharmaCompass.
L-polamidon (TN) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L-polamidon (TN) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right L-polamidon (TN) GMP manufacturer or L-polamidon (TN) GMP API supplier for your needs.
A L-polamidon (TN) CoA (Certificate of Analysis) is a formal document that attests to L-polamidon (TN)'s compliance with L-polamidon (TN) specifications and serves as a tool for batch-level quality control.
L-polamidon (TN) CoA mostly includes findings from lab analyses of a specific batch. For each L-polamidon (TN) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L-polamidon (TN) may be tested according to a variety of international standards, such as European Pharmacopoeia (L-polamidon (TN) EP), L-polamidon (TN) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L-polamidon (TN) USP).
